for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Compugroup Medical SE

COPMa.DE

Latest Trade

64.80EUR

Change

1.85(+2.94%)

Volume

68,363

Today's Range

63.20

 - 

64.85

52 Week Range

42.08

 - 

74.80

As of on the XETRA ∙ Minimum 15 minute delay

Latest Developments

Compugroup Medical Buys H&S Qualita nel Software

Jan 8 (Reuters) - COMPUGROUP MEDICAL SE <COPMa.DE>::COMPUGROUP MEDICAL SE ACQUIRES ITALIAN COMPANY H&S QUALITÀ NEL SOFTWARE SPA.

Compugroup Medical Buys Epsilog

Dec 27 (Reuters) - COMPUGROUP MEDICAL SE <COPMa.DE>::COMPUGROUP MEDICAL ACQUIRES EPSILOG.CLOSING OF TRANSACTION IS EXPECTED FOR 27 DECEMBER 2019..SIGNED AN AGREEMENT REGARDING SALE AND PURCHASE OF 100 % OF SHARES IN MB INVEST SAS WHICH IS SOLE OWNER OF EPSILOG SAS (EPSILOG).AGREED PURCHASE PRICE FOR EPSILOG AMOUNTS TO EUR 72M AND IS SUBJECT TO FURTHER ADJUSTMENTS POST-CLOSING.

Compugroup Medical Confirms 2019 Guidance

Nov 7 (Reuters) - Compugroup Medical SE <COPMa.DE>::Q3 REVENUES OF 178 MILLION EUR.Q3 EBITDA OF 43 MILLION EUR.Q3 NET INCOME OF 25 MILLION EUR.CONFIRMS 2019 GUIDANCE.

Compugroup Medical Resolves Share Buyback

Sept 17 (Reuters) - Compugroup Medical SE <COPMa.DE>::DGAP-ADHOC: COMPUGROUP MEDICAL SE: MANAGEMENT BOARD OF COMPUGROUP MEDICAL SE DECIDES SHARE BUYBACK.UP TO 930,825 SHARES OF COMPANY SHALL BE REPURCHASED,.PORTION OF CURRENT NOMINAL SHARE CAPITAL OF APPROXIMATELY 1.75%.SUBJECT TO AN OVERALL PURCHASE VOLUME LIMIT OF EUR 48,400,000.00.SHARE BUYBACK WILL BE CARRIED OUT IN TIME PERIOD FROM SEPTEMBER 18, 2019 UNTIL MARCH 31, 2020.

Compugroup Medical Says Now Expecting EBITDA For FY 2019 In Range Of Eur 175 Mln To Eur 190 Mln

Sept 15 (Reuters) - Compugroup Medical SE <COPMa.DE>::DGAP-ADHOC: COMPUGROUP MEDICAL REDUCES FY 2019 EBITDA GUIDANCE DUE TO ONE-OFF COSTS FOR ABANDONED MAJOR M&A TRANSACTION.IS NOW EXPECTING AN EBITDA FOR FULL YEAR 2019 IN RANGE OF EUR 175 MILLION TO EUR 190 MILLION.SAYS EXPECTED RANGE FOR REVENUES IN CURRENT YEAR CONTINUES TO BE UNCHANGED AT EUR 720 MILLION TO EUR 750 MILLION..

Compugroup Medical SE Reaffirms 2019 Guidance After Q2

Aug 8 (Reuters) - Compugroup Medical SE <COPMa.DE>::DGAP-NEWS: COMPUGROUP MEDICAL SE REAFFIRMS GUIDANCE FOR 2019.CONSOLIDATED REVENUE WAS AROUND EUR 187 MILLION, JUST SLIGHTLY BELOW EXCEPTIONAL QUARTER OF PREVIOUS YEAR.CONSOLIDATED EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (EBITDA) ON A PRO FORMA BASIS AMOUNTED TO EUR 44 MILLION IN Q2 OF 2019, WITH AN OPERATING MARGIN OF 24%.GUIDANCE FOR FULL YEAR 2019 WITH REVENUES IN AMOUNT OF EUR 720 TO 750 MILLION AND AN EBITDA OF EUR 190 TO 205 MILLION IS REAFFIRMED.PRO FORMA OPERATING RESULT IN Q2 AMOUNTED TO EUR 44.3 MILLION AND WAS THUS, AS EXPECTED, EUR 10 MILLION LOWER THAN THAT OF EXTRAORDINARY PRIOR-YEAR QUARTER.AN ADJUSTMENT TO ACCOUNTING OF STOCK OPTIONS IN COURSE OF RESIGNATION OF A MEMBER OF MANAGEMENT BOARD LEADS TO A REPORTED EBITDA FOR Q2 OF EUR 37.4 MILLION AND WILL BURDEN FULL 2019 YEAR WITH EUR 3.9 MILLION.WE SEE OURSELVES ON TRACK TO ACHIEVE OUR 2019 EBITDA AMBITION, EVEN DESPITE THIS ONE-OFF EFFECT.

Compugroup Medical Says Q1 Revenue Up 5.4 Pct To 175 Mln Eur

May 6 (Reuters) - Compugroup Medical SE <COPMa.DE>::DGAP-NEWS: COMPUGROUP MEDICAL SE REPORTS RESULTS FOR FIRST QUARTER OF 2019.Q1 REVENUE 175 MILLION EUR VERSUS 166 MILLION EUR YEAR AGO.GENERATED A REVENUE OF EUR 175 MILLION COMPARED TO EUR 166 MILLION IN SAME PERIOD OF PREVIOUS YEAR.CONFIRMS FORECAST FOR FISCAL YEAR OF 2019.CONSOLIDATED EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA) AND OPERATING MARGIN BOTH ROSE TO EUR 50 MILLION AND 28 PERCENT IN Q1 OF 2019.REFINITIV POLL AVG WAS Q1 EBITDA OF 46.0 MLN EUR, REVENUES OF 173 MLN EUR.

Compugroup Medical: Changes To Management Board

April 15 (Reuters) - COMPUGROUP MEDICAL SE <COPMa.DE>::UPCOMING CHANGES TO THE CGM MANAGEMENT BOARD.CHRISTIAN TEIG WILL BE DEPARTING FROM HIS POSITION AS CHIEF FINANCIAL OFFICER EFFECTIVE JULY 31, 2019.HAS APPOINTED MICHAEL RAUCH WHO WILL TAKE OVER AS NEW CFO FROM AUGUST 1, 2019.

Compugroup Medical Sees 2019 Organic Growth Of -3 to +2 Pct

March 29 (Reuters) - Compugroup Medical SE <COPMa.DE>::2019 REVENUES EXPECTED TO BE IN RANGE OF EUR 720 MILLION TO 750 MILLION.2019 EBITDA EXPECTED TO BE IN RANGE OF 190 TO 205 MILLION EUR.SEES 2019 ORGANIC GROWTH OF -3 PERCENT TO +2 PERCENT.

Compugroup Medical Proposes Dividend Increase To EUR 0.50 Per Share

Feb 26 (Reuters) - COMPUGROUP MEDICAL SE <COPMa.DE>::MANAGEMENT BOARD OF COMPUGROUP MEDICAL SE PROPOSES DIVIDEND INCREASE TO 0.50 EUR.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up